ConductScience.org, home

Paper59012

Immunisation against hepatitis B in man.

Maupas P and 4 others. Lancet, 1976. Cited by 188 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunisation against hepatitis B in man. Papers, record 59012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/59012

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunisation against hepatitis B in man.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
188
iCite
Relative citation ratio, by iCite
5.54
iCite
Revised in PubMed
2019-06-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maupas PP
2Goudeau AA
3Coursaget PP
4Drucker JJ
5Bagros PP

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Hepatitis B AntigensMajor topic
VaccinationMajor topic
Viral VaccinesMajor topic
Animals
Humans
Liver
Pan troglodytes

Source PubMed

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 188 citations.

PMIDTitleJournalYearIn PapersSource
40,210,771Hepatitis B virus infection after immunization: How serious it is? An updated review.Clin Exp Med2025https://conductscience.org/library/papers/40210771PubMed
39,861,834Unveiling the Molecular Architecture of HBV Spherical Subviral Particles: Structure, Symmetry, and Lipid Dynamics.Viruses2024https://conductscience.org/library/papers/39861834PubMed
39,281,486An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination.Heliyon2024https://conductscience.org/library/papers/39281486PubMed
38,675,820Hepatitis B Vaccine: Four Decades on.Vaccines (Basel)2024https://conductscience.org/library/papers/38675820PubMed
37,400,485Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes.Sci Rep2023https://conductscience.org/library/papers/37400485PubMed
35,409,035Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses.Int J Mol Sci2022https://conductscience.org/library/papers/35409035PubMed
35,015,108[Hepatitis B vaccines-history, achievements, challenges, and perspectives].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz2022https://conductscience.org/library/papers/35015108PubMed
32,937,642Finding the key to solving problems in the hepatitis kingdom: A Study on the Development of Hepatitis B Vaccine by Kim Chung Young in the 1960-70s.Uisahak2020https://conductscience.org/library/papers/32937642PubMed
32,759,756Advances with RNAi-Based Therapy for Hepatitis B Virus Infection.Viruses2020https://conductscience.org/library/papers/32759756PubMed
31,973,017Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.Viruses2020https://conductscience.org/library/papers/31973017PubMed
30,945,969B-cell restriction - an alternative piece to the puzzle.Hum Vaccin Immunother2019https://conductscience.org/library/papers/30945969PubMed
28,511,068Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.Stud Hist Philos Biol Biomed Sci2017https://conductscience.org/library/papers/28511068PubMed
28,468,285Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks.Viruses2017https://conductscience.org/library/papers/28468285PubMed
27,157,411Vaccine technologies: From whole organisms to rationally designed protein assemblies.Biochem Pharmacol2016https://conductscience.org/library/papers/27157411PubMed
26,978,406Hepatitis Vaccines.Vaccines (Basel)2016https://conductscience.org/library/papers/26978406PubMed
26,097,629[Prevalence of hepatitis B in people infected with HIV in Parakou in Benin].Pan Afr Med J2015https://conductscience.org/library/papers/26097629PubMed
25,523,195Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Med Microbiol Immunol2015https://conductscience.org/library/papers/25523195PubMed
24,310,062DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.Cancer Gene Ther2013https://conductscience.org/library/papers/24310062PubMed
23,870,415Medical virology of hepatitis B: how it began and where we are now.Virol J2013https://conductscience.org/library/papers/23870415PubMed
23,577,080A mouse model for studying the clearance of hepatitis B virus in vivo using a luciferase reporter.PLoS One2013https://conductscience.org/library/papers/23577080PubMed

See all 34 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/59012

GET https://conductscience.org/api/papers/v1/59012/cited_by?page=2